HEPATITIS B CORE ANTIGEN POSITIVE

This adverse event was reported 38 times

HEPATITIS B CORE ANTIGEN POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN 2 0.0041
1 HUMAN IMMUNOGLOBULIN G 8 0.0004
2 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 2 0.0003
3 MEGESTROL ACETATE 1 0.0003
4 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 1 0.0002
5 ATOVAQUONE 1 0.0001
6 PHYTONADIONE 1 0.0001
7 TRANEXAMIC ACID 1 0.0001
8 MAGNESIUM SULFATE HEPTAHYDRATE 1 0.0001
9 LOPINAVIR AND RITONAVIR 1 0.0001
See all drugs enriched for association with HEPATITIS B CORE ANTIGEN POSITIVE

HEPATITIS B CORE ANTIGEN POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 9 0.0004
1 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
2 Vitamin K [EPC] 1 0.0001
3 Sigma-1 Agonist [EPC] 1 0.0001
4 Antifibrinolytic Agent [EPC] 1 0.0001
5 Antimalarial [EPC] 1 0.0001
6 Antiprotozoal [EPC] 1 0.0001
7 Potassium-sparing Diuretic [EPC] 1 0.0001
8 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
9 Alkaloid [EPC] 1 0.0000
See all drug classes enriched for association with HEPATITIS B CORE ANTIGEN POSITIVE